Medios

Medios Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Medios (ILM1.DE) as of Nov 18, 2026 is 0.53. In the previous year, Cash Conversion Cycle (CCC) was 23.25 — a change of -97.71% (lower).

Cash Conversion Cycle

0.53

YoY

-97.71%

Last updated:

Cash Conversion Cycle (CCC) of Medios is 2025 0.53 . Cash Conversion Cycle (CCC) of Medios was 2024 23.25 . It decreases by -97.71% lower compared to the previous year.

The Medios Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
27.97 EUR
Jan 1, 2019
32.12 EUR
Jan 1, 2020
50.90 EUR
Jan 1, 2021
24.23 EUR
Jan 1, 2022
24.25 EUR
Jan 1, 2023
26.51 EUR
Jan 1, 2024
23.25 EUR
Jan 1, 2025
0.53 EUR
The Medios Cash Conversion Cycle history
YEARCash Conversion CycleYoY
0.53-97.71%
23.25-12.31%
26.51+9.31%
24.25+0.08%
24.23-52.40%
50.90+58.50%
32.12+14.82%
27.97+30.02%
21.51-28.92%
30.27-100.00%
4.38 M-3,479.25%
-129,752.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medios Stock analysis

What does Medios do? Medios AG is a leading company in the supply of high-quality specialty preparations to patients. The company was founded in Berlin in 2004 and has been listed on the Frankfurt Stock Exchange since 2018. Medios AG quickly achieved a strong position in the German healthcare market and currently employs approximately 300 employees at multiple locations in Germany. The business model of Medios AG is based on the production and distribution of high-quality specialty preparations. These are developed and produced in close collaboration with customers such as hospitals and outpatient clinics. Medios AG's products are typically used to treat rare and chronic diseases, such as immunological diseases, cancer, and metabolic disorders. Medios AG offers a wide range of products and services. The company is divided into three areas. The first area is Medios AG's core business, the distribution of specialty preparations. This area includes the development, production, and distribution of specialty preparations. The portfolio includes, for example, medications for pain and inflammation, as well as preparations for the treatment of Parkinson's and Alzheimer's diseases. Another important aspect in the field of specialty preparations is the supply of patients with parenteral nutrition solutions. These are used in both outpatient and inpatient settings to provide care for patients with severe diseases. The second area is supply services. Here, Medios offers a comprehensive range of services to support customers in hospital care and outpatient patient care. An important aspect of this area is the support of hospitals in dealing with delegations. For example, training is offered to educate hospital staff on the management of certain diseases. The third area is clinical study support. Medios AG offers services and products to support customers in clinical studies. The range includes criteria for patient-related logistics, the delivery of placebos and blinded medications, as well as specialty preparations and parenteral nutrition solutions. In each of these areas, Medios brings its high expertise and experience to develop the best possible solutions for customers and patients. Overall, Medios AG has established itself as an important partner for the German healthcare sector. The company pursues a clear strategy focused on the development and production of specialty preparations for the treatment of serious and rare diseases. The company places the highest value on the quality and safety of its products, as well as comprehensive consultation and customer care. Medios has a strong network of partners and suppliers in the healthcare industry and is a respected contact for customers and other market participants due to its experience and expertise. Medios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medios stock

Cash Conversion Cycle (CCC) of Medios is 0.53 in 2025.

Cash Conversion Cycle (CCC) of Medios changed from 23.25 to 0.53, representing a -97.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Medios since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Medios with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Medios

All Key Metrics — Medios